HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jnumed.107.048900v1 49/4/679    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JNM Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zanotti-Fregonara, P. Articles by Hindié, E. Search for Related Content PubMed PubMed Citation Articles by Zanotti-Fregonara, P. Articles by Hindié, E.

Estimation of the β+ Dose to the Embryo Resulting from ¹⁸F-FDG Administration During Early Pregnancy

¹ DSV/I²BM/SHFJ/LIME, Commissariat à l'Energie Atomique, Orsay, France; ² Laboratoire de Physique Moléculaire et des Collisions, Université Paul Verlaine-Metz Institut de Physique, Metz, France; ³ Médecine Nucléaire, Hôpital Saint Antoine, Paris, France; ⁴ Médecine Nucléaire, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France; and ⁵ Imagerie Moléculaire pour le Diagnostique et le Ciblage Thérapeutique, Ecole Doctorale B2T, IUH, Université Paris 7, Paris, France

Correspondence: For correspondence or reprints contact: Elif Hindié, Hôpital Saint-Louis, Service de Médecine Nucléaire, 1, avenue Claude Vellefaux, 75475 Paris Cedex 10, France. E-mail: elif.hindie{at}sls.aphp.fr

Although ¹⁸F-FDG examinations are widely used, data are lacking on the dose to human embryo tissues in cases of exposure in early pregnancy. Although the photon component can easily be estimated from available data on the pharmacokinetics of ¹⁸F-FDG in female organs and from phantom measurements (considering the uterus as the target organ), the intensity of embryo tissue uptake, which is essential for deriving the β+ dose, is not known. We report the case of a patient who underwent ¹⁸F-FDG PET/CT for tumor surveillance and who was later found to have been pregnant at the time of the examination (embryo age, 8 wk). Methods: The patient received 320 MBq of ¹⁸F-FDG. Imaging started with an unenhanced CT scan 1 h after the injection, followed by PET acquisition. PET images were used to compute the total number of β+ emissions in embryo tissues per unit of injected activity, from standardized uptake value (SUV) measurements corrected for partial-volume effects. A Monte Carlo track structure code was then used to derive the β+ self-dose and the β+ cross-dose from amniotic fluid. The photon and CT doses were added to obtain the final dose received by the embryo. Results: The mean SUV in embryo tissues was 2.7, after correction for the partial-volume effect. The mean corrected SUV of amniotic fluid was 1.1. Monte Carlo simulation showed that the β+ dose to the embryo (self-dose plus cross-dose from amniotic fluid) was 1.8E–2 mGy per MBq of injected ¹⁸F-FDG. Based on MIRD data for the photon dose to the uterus, the estimated photon dose to the embryo was 1.5E–2 mGy/MBq. Thus, the specific ¹⁸F-FDG dose to the embryo was 3.3E–2 mGy/MBq (10.6 mGy in this patient). The CT scan added a further 8.3 mGy. Conclusion: The dose to the embryo is 3.3E–2 mGy/MBq of ¹⁸F-FDG. The β+ dose contributes 55% of the total dose. This value is higher than previous estimates in late nonhuman-primate pregnancies.

Key Words: ¹⁸F-FDG • embryo dosimetry • Monte Carlo simulation

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.

Related articles in JNM:

This Month in JNM

JNM 2008 49: 11A-12A. [Full Text]  

This article has been cited by other articles:

				T. A. Jaffe, A. M. Neville, C. Anderson-Evans, S. Long, C. Lowry, T. T. Yoshizumi, and G. Toncheva Early First Trimester Fetal Dose Estimation Method in a Multivendor Study of 16- and 64-MDCT Scanners and Low-Dose Imaging Protocols Am. J. Roentgenol., October 1, 2009; 193(4): 1019 - 1024. [Abstract] [Full Text] [PDF]